featured
Effects of Ertugliflozin on Uric Acid Levels and Gout-Related Outcomes in People With Type 2 Diabetes and CVD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV
Diabetes Obes Metab 2024 Sep 02;[EPub Ahead of Print], VS Sridhar, F Cosentino, S Dagogo-Jack, DK McGuire, RE Pratley, NB Cater, M Noyes Essex, JP Mancuso, Y Zhao, DZI CherneyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.